Immune escape via myeloid-derived suppressor cells in solid tumor cancer patients treated with anchored IL-12? (tolododekin alfa)

tolododekin alfa (ANK-101) - Ankyra Therap

https://www.abstractsonline.com/pp8/#!/21436/presentation/12048

Wiem Lassoued1; Sailaja Battula2; Lisa Sturla2; Jong C. Park3; Brendan Curti4; Marcus O. Butler5; John M. Kirkwood6; Howard L. Kaufman2; James L. Gulley1

Mar 18, 2026